ERBB2 and ductal breast carcinoma in situ: We investigated two DCIS cell lines, MCF10DCIS.com (ErbB2 normal) and SUM225 (ErbB2 overexpressing), and 7 human primary DCIS samples taken from patients after surgery with ErbB2 positive or negative molecular subtypes.